US 12076371
Activatable cytokine polypeptides and methods of use thereof
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 12076371 (Activatable cytokine polypeptides and methods of use thereof) held by Werewolf Therapeutics, Inc. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Werewolf Therapeutics, Inc.
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K35/17